Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Bausch Health Companies (BHC) PT Lowered to $25 at BMO Capital
February 21, 2019 9:35 AM ESTBMO Capital analyst Gary Nachman lowered the price target on Bausch Health Companies (NYSE: BHC) to $25.00 (from $26.00) while maintaining a Market Perform rating.
Nachman notes BHC delivered relatively in-line 4Q and 2019 guidance overall roughly in-line with expectations, although bottom-end of revenue range... More
Bausch Health Co. Inc. (BHC) Q4 Revenue Tops Views, Guidance Misses at Mid-Point
February 20, 2019 7:05 AM ESTBausch Health Co. Inc. (NYSE: BHC) reported Q4 EPS of ($0.98), may not compare to the analyst estimate of $0.84. Revenue for the quarter came in at $2.12 billion versus the consensus estimate of $2.08 billion.
GUIDANCE:
Bausch Health Co. Inc. sees FY2019 revenue... More
